BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35607848)

  • 1. Oncological Outcomes of Retroperitoneal Lymph Node Dissection During Retroperitoneal Laparoscopic Radical Nephroureterectomy for Renal Pelvic or Upper Ureteral Tumors: Matched-Pair Analysis.
    Kanno T; Kobori G; Ito K; Nakagawa H; Takahashi T; Koterazawa S; Takaoka N; Somiya S; Nagahama K; Ito M; Megumi Y; Higashi Y; Moroi S; Akao T; Yamada H
    J Endourol; 2022 Sep; 36(9):1206-1213. PubMed ID: 35607848
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardized and Simplified Retroperitoneal Lymph Node Dissection During Retroperitoneal Laparoscopic Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Ureter or Renal Pelvis: En Bloc Resection Technique.
    Kanno T; Kobori G; Kubota M; Funada S; Haitani T; Okada T; Higashi Y; Moroi S; Yamada H
    Urology; 2018 Feb; 112():85-91. PubMed ID: 29158173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications and their management following retroperitoneal lymph node dissection in conjunction with retroperitoneal laparoscopic radical nephroureterectomy.
    Kanno T; Kobori G; Ito K; Nakagawa H; Takahashi T; Takaoka N; Somiya S; Nagahama K; Ito M; Megumi Y; Higashi Y; Moroi S; Akao T; Yamada H
    Int J Urol; 2022 May; 29(5):455-461. PubMed ID: 35144321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection.
    Abe T; Kondo T; Harabayashi T; Takada N; Matsumoto R; Osawa T; Minami K; Nagamori S; Maruyama S; Murai S; Tanabe K; Shinohara N
    Jpn J Clin Oncol; 2018 Nov; 48(11):1001-1011. PubMed ID: 30272169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
    Childs MA; Wood CG; Spiess PE; Debiane LG; Hernandez M; Matin SF; Millikan RE; Siefker-Radtkie A; Scott SM; Pisters LL
    Can J Urol; 2010 Jun; 17(3):5184-9. PubMed ID: 20566011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
    Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR
    Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes of laparoscopic radical nephroureterectomy in conjunction with template-based lymph node dissection: An extended follow-up study.
    Matsumoto R; Abe T; Takada N; Minami K; Harabayashi T; Nagamori S; Hatanaka KC; Yamashiro K; Kikuchi H; Osawa T; Maruyama S; Shinohara N
    Urol Oncol; 2020 Dec; 38(12):933.e13-933.e18. PubMed ID: 32534960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
    Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
    Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.
    Corvin S; Kuczyk M; Anastasiadis A; Stenzl A
    World J Urol; 2004 Apr; 22(1):33-6. PubMed ID: 15034741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma.
    Rao SR; Correa JJ; Sexton WJ; Pow-Sang JM; Dickinson SI; Lin HY; Spiess PE
    BJU Int; 2012 Dec; 110(11 Pt B):E475-80. PubMed ID: 22564727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching.
    Shigeta K; Matsumoto K; Takeda T; Hattori S; Kaneko G; Matsushima M; Abe T; Tanaka N; Mizuno R; Asanuma H; Kikuchi E; Oya M
    Ann Surg Oncol; 2021 Jan; 28(1):465-473. PubMed ID: 32840743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Harris KT; Gorin MA; Ball MW; Pierorazio PM; Allaf ME
    BJU Int; 2015 Dec; 116(6):920-3. PubMed ID: 25781349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.
    Rassweiler JJ; Seemann O; Henkel TO; Stock C; Frede T; Alken P
    J Urol; 1996 Sep; 156(3):1108-13. PubMed ID: 8709319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.
    Gardner MW; Roytman TM; Chen C; Brandes SB; Kibel AS; Grubb RL; Bhayani SB; Figenshau RS
    J Endourol; 2011 Nov; 25(11):1753-7. PubMed ID: 21936630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection.
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
    J Endourol; 2013 Jul; 27(7):856-61. PubMed ID: 23516988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.
    Bhayani SB; Ong A; Oh WK; Kantoff PW; Kavoussi LR
    Urology; 2003 Aug; 62(2):324-7. PubMed ID: 12893344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma.
    Barboza MP; Speir RW; Boris RS; Calaway AC; Cary C; Foster RS; Masterson TA
    Urol Oncol; 2020 Sep; 38(9):739.e1-739.e8. PubMed ID: 32646691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.